CYSTIC FIBROSIS LUNG
Clinical trials for CYSTIC FIBROSIS LUNG explained in plain language.
Never miss a new study
Get alerted when new CYSTIC FIBROSIS LUNG trials appear
Sign up with your email to follow new studies for CYSTIC FIBROSIS LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled gene therapy aims to tackle cystic fibrosis lung damage
Disease control Recruiting nowThis study tests a new gene therapy called 4D-710 for adults with cystic fibrosis (CF) who cannot take or have stopped standard CF medications. The therapy is given as a single inhaled dose and aims to deliver a working gene to lung cells to help clear mucus and improve breathing…
Matched conditions: CYSTIC FIBROSIS LUNG
Phase: PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New inhaled therapy targets tough lung infections in cystic fibrosis
Disease control Recruiting nowThis study tests an experimental inhaled drug called RSP-1502 in people with cystic fibrosis who have a chronic lung infection from Pseudomonas bacteria. The goal is to check the drug's safety and how the body processes it. About 72 participants aged 12 and older will receive eit…
Matched conditions: CYSTIC FIBROSIS LUNG
Phase: PHASE1, PHASE2 • Sponsor: Respirion Pharmaceuticals Pty Ltd • Aim: Disease control
Last updated May 13, 2026 15:58 UTC